Skip to main content

Advertisement

Springer Nature Link
Log in

Development of transcriptomic biomarker signature in human saliva to detect lung cancer

  • Research Article
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

Lung cancer is the leading cause of cancer death for both men and women worldwide. Since most of the symptoms found for lung cancer are nonspecific, diagnosis is mostly done at late and progressed stage with the consecutive poor therapy outcome. Effective early detection techniques are sorely needed. The emerging field of salivary diagnostics could provide scientifically credible, easy-to-use, non-invasive and cost-effective detection methods. Recent advances have allowed us to develop discriminatory salivary biomarkers for a variety of diseases from oral to systematic diseases. In this study, salivary transcriptomes of lung cancer patients were profiled and led to the discovery and pre-validation of seven highly discriminatory transcriptomic salivary biomarkers (BRAF, CCNI, EGRF, FGF19, FRS2, GREB1, and LZTS1). The logistic regression model combining five of the mRNA biomarkers (CCNI, EGFR, FGF19, FRS2, and GREB1) could differentiate lung cancer patients from normal control subjects, yielding AUC value of 0.925 with 93.75 % sensitivity and 82.81 % specificity in the pre-validation sample set. These salivary mRNA biomarkers possess the discriminatory power for the detection of lung cancer. This report provides the proof of concept of salivary biomarkers for the non-invasive detection of the systematic disease. These results poised the salivary biomarkers for the initiation of a multi-center validation in a definitive clinical context.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CT:

Computerized tomography

MACs:

Malignancy-associated changes

ROC:

Receiver-operating characteristic

AUC:

Calculation of the area under the curve

qPCR:

Quantitative polymerase chain reaction

COPD:

Chronic obstructive pulmonary disease

EGFR:

Epidermal growth factor receptor

BRAF:

v-raf murine sarcoma viral oncogene homolog B1

LZTS1:

Leucine zipper, putative tumor suppressor 1

References

  1. Jemal A, Siegel R, Xu JQ, Ward E (2010) Cancer Statistics, 2010. CA Cancer J Clin 60:277–300

    Article  PubMed  Google Scholar 

  2. Hecht SS (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3:461–469

    Article  PubMed  CAS  Google Scholar 

  3. Spira A, Beane J, Shah V, Liu G, Schembri F, Yang XM, Palma J, Brody JS (2004) Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 101:10143–10148

    Article  PubMed  CAS  Google Scholar 

  4. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, Gilman S, Dumas YM, Calner P, Sebastiani P, Sridhar S, Beamis J, Lamb C, Anderson T, Gerry N, Keane J, Lenburg ME, Brody JS (2007) Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 13:361–366

    Article  PubMed  CAS  Google Scholar 

  5. Petty TL (2000) The early identification of lung carcinoma by sputum cytology. Cancer 89:2461–2464

    Article  PubMed  CAS  Google Scholar 

  6. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A, Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken M, Plunkett M, Price H, Reding D, Riley T, Schwartz M, Spizarny D, Yoffie R, Zylak C (2005) Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 47:9–15

    Article  PubMed  Google Scholar 

  7. Singh S, Pinsky P, Fineberg NS, Gierada DS, Garg K, Sun YH, Nath PH (2011) Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Radiology 259:263–270

    Article  PubMed  Google Scholar 

  8. Gray RD, Duncan A, Noble D, Imrie M, O’Reilly DSJ, Innes A, Porteous DJ, Greening AP, Boyd AC (2010) Sputum trace metals are biomarkers of inflammatory and suppurative lung disease. Chest 137:635–641

    Article  PubMed  CAS  Google Scholar 

  9. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017–2019

    Article  PubMed  CAS  Google Scholar 

  10. Gessner C, Rechner B, Hammerschmidt S, Kuhn H, Hoheisel G, Sack U, Ruschpler P, Wirtz H (2010) Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer 68:177–184

    Article  PubMed  CAS  Google Scholar 

  11. Lacroix J, Becker HD, Woerner SM, Rittgen W, Drings P, von Knebel Doeberitz M (2001) Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR. Int J Cancer 92:1–8

    Article  PubMed  CAS  Google Scholar 

  12. Taylor MD, Smith PW, Brix WK, Wick MR, Theodosakis N, Swenson BR, Kozower BD, Lau CL, Jones DR (2009) Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer. J Thorac Cardiovasc Surg 137:43–48

    Article  PubMed  Google Scholar 

  13. Miller YE, Vu KO, Kennedy TC, Hirsch FR, Petty TL, Bunn PA, Keith RL, Franklin WA, Wolf HJ, Prindiville S, Byers T (2006) Lack of association between sputum atypia and chronic obstructive pulmonary disease mortality. J Thorac Oncol 1:302–307

    Article  PubMed  Google Scholar 

  14. Xiao H, Wong DT (2011) Proteomics and its applications for biomarker discovery in human saliva. Bioinformation 5:294–296

    Article  PubMed  Google Scholar 

  15. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong DT (2010) Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 138:949–957

    Article  PubMed  CAS  Google Scholar 

  16. Gonzalez-Begne M, Lu BW, Han XM, Hagen FK, Hand AR, Melvin JE, Yates JR (2009) Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res 8:1304–1314

    Article  PubMed  CAS  Google Scholar 

  17. Wong DT (2006) Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 137:313–321

    PubMed  CAS  Google Scholar 

  18. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C (2008) Diagnostic potential of saliva: current state and future applications. Clin Chem 57:675–687

    Article  Google Scholar 

  19. Zhang L, Xiao H, Wong DT (2009) Salivary biomarkers for clinical applications. Mol Diagn Ther 13:245–259

    Article  PubMed  CAS  Google Scholar 

  20. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT (2008) Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14:6246–6252

    Article  PubMed  CAS  Google Scholar 

  21. Li Y, St John MAR, Zhou X, Kim Y, Sinha U, Jordan RCK, Eisele D, Abemayor E, Elashoff D, Park N-H, Wong DT (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10:8442–8450

    Article  PubMed  CAS  Google Scholar 

  22. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM (2005) The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 3:27

    Article  PubMed  CAS  Google Scholar 

  23. Wei F, Patel P, Liao W, Chaudhry K, Zhang L, Arellano-Garcia M, Hu S, Elashoff D, Zhou H, Shukla S, Shah F, Ho C-M, Wong DT (2009) Electrochemical sensor for multiplex biomarkers detection. Clin Cancer Res 15:4446–4452

    Article  PubMed  CAS  Google Scholar 

  24. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, Zhou H, Henry S, Vissink A, Pijpe J, Kallenberg C, Elashoff D, Loo JA, Wong DT (2007) Salivary proteomic and genomic biomarkers for primary Sjögren’s syndrome. Arthritis Rheum 56:3588–3600

    Article  PubMed  CAS  Google Scholar 

  25. Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, Akin D, Yan X, Chia D, Karlan B, Wong DT (2010) Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One 5:e15573

    Article  PubMed  CAS  Google Scholar 

  26. Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT (2012) Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics 11:M111.012112

    Google Scholar 

  27. Edgar R, Barrett T (2006) NCBI GEO standards and services for microarray data. Nat Biotechnol 24:1471–1472

    Article  PubMed  CAS  Google Scholar 

  28. Therneau TM, Ballman KV (2008) What does PLIER really do? Cancer Inf 6:423–431

    CAS  Google Scholar 

  29. Hu ZZ, Zimmermann BG, Zhou H, Wang JH, Henson BS, Yu WX, Elashoff D, Krupp G, Wong DT (2008) Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. Clin Chem 54:824–832

    Article  PubMed  CAS  Google Scholar 

  30. Jessie K, Pang WW, Rahim ZHA, Hashim OH (2010) Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers. Int J Mol Sci 11:4488–4505

    Article  PubMed  CAS  Google Scholar 

  31. Vanni H, Kazeros A, Wang R, Harvey BG, Ferris B, De BP, Carolan BJ, Hubner RH, O’Connor TP, Crystal RG (2009) Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human. Chest 135:1197–1208

    Article  PubMed  CAS  Google Scholar 

  32. Molina R, Auge JM, Escudero JM, Marrades R, Vinolas N, Carcereny E, Ramirez J, Filella X (2008) Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE. Tumor Biol 29:371–380

    Article  CAS  Google Scholar 

  33. Molina R, Filella X, Auge JM, Fuentes R, Bover I, Rifa J, Moreno V, Canals E, Vinolas N, Marquez A, Barreiro E, Borras J, Viladiuc P (2003) Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis—comparison with the main clinical and pathological prognostic factors. Tumor Biol 24:209–218

    Article  CAS  Google Scholar 

  34. Shitrit D, Zingerman B, Shitrit ABG, Shlomi D, Kramer MR (2005) Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist 10:501–507

    Article  PubMed  CAS  Google Scholar 

  35. Li Y, Zhou X, John M, Wong DTW (2004) RNA profiling of cell-free saliva using microarray technology. J Dent Res 83:199–203

    Article  PubMed  CAS  Google Scholar 

  36. Park NJ, Li Y, Yu TW, Brinkman BMN, Wong DT (2006) Characterization of RNA in saliva. Clin Chem 52:988–994

    Article  PubMed  CAS  Google Scholar 

  37. Balko JM, Potti A, Saunders C, Stromberg A, Haura EB, Black EP (2006) Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors. BMC Genomics 7:289

    Article  PubMed  Google Scholar 

  38. Shibata T, Hanada S, Kokubu A, Matsuno Y, Asamura H, Ohta T, Sakamoto M, Hirohashi S (2007) Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma. Cancer Sci 98:985–991

    Article  PubMed  CAS  Google Scholar 

  39. Nonaka D, Fabbri A, Roz L, Mariani L, Vecchione A, Moore GW, Tavecchio L, Croce CM, Sozzi G (2005) Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer. Cancer Res 65:1207–1212

    Article  PubMed  CAS  Google Scholar 

  40. Kobayashi S, Boggon TJ, Dayaram T, Janne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B (2005) EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352:786–792

    Article  PubMed  CAS  Google Scholar 

  41. Sordella R, Bell DW, Haber DA, Settleman J (2004) Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305:1163–1167

    Article  PubMed  CAS  Google Scholar 

  42. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497–1500

    Article  PubMed  CAS  Google Scholar 

  43. Herbst RS, Heymach JV, Lippman SM (2008) Molecular origins of cancer: lung cancer. N Engl J Med 359:1367–1380

    Article  PubMed  CAS  Google Scholar 

  44. Schmid K, Oehl N, Wrba F, Pirker R, Pirker C, Filipits M (2009) EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases. Clin Cancer Res 15:4554–4560

    Article  PubMed  CAS  Google Scholar 

  45. Desnoyers LR, Pai R, Ferrando RE, Hotzel K, Le T, Ross J, Carano R, D’Souza A, Qing J, Mohtashemi I, Ashkenazi A, French DM (2008) Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene 27:85–97

    Article  PubMed  CAS  Google Scholar 

  46. Sato T, Gotoh N (2009) The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment. Expert Opin Ther Targets 13:689–700

    Article  PubMed  CAS  Google Scholar 

  47. Pleasance ED, Stephens PJ, O’Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordonez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen LN, Jia MM, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463:184–190

    Article  PubMed  CAS  Google Scholar 

  48. Church TR, Anderson KE, Caporaso NE, Geisser MS, Le CT, Zhang Y, Benoit AR, Carmella SG, Hecht SS (2009) A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 18:260–266

    Article  PubMed  CAS  Google Scholar 

  49. Gao K, Zhou H, Zhang L, Lee JW, Zhou Q, Hu S, Wolinsky LE, Farrell J, Eibl G, Wong DT (2009) Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS One 4:e5875

    Article  PubMed  Google Scholar 

  50. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD (2008) Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst 100:1432–1438

    Article  PubMed  CAS  Google Scholar 

  51. Landberg G, Nilsson K, Jirstrom K, Ryden L, Kitching R, Burger AM, Seth A (2005) Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression. Breast Cancer Res Treat 89:313–316

    Article  PubMed  CAS  Google Scholar 

  52. Ghosh MG, Thompson DA, Weigel RJ (2000) PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60:6367–6375

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Supported by the University of California Tobacco Research Related Research Program (TRDRP, 20PT-0032) and DOD Lung Cancer Research Program (LC110207). DTWW is also supported by the Felix & Mildred Yip Endowed Professorship.

Conflict of interest

HX, LZ, HZ, and DTWW have patent application (US 2011/0207622 A1) pertaining to this work. DTWW is the co-founder of RNAmeTRIX. The other authors disclosed no potential conflicts of interests.

Author information

Author notes

  1. Hui Zhou

    Present address: Genome Sciences Resource, Vanderbilt University Medical Center, Nashville, TN, USA

Authors and Affiliations

  1. School of Dentistry and Dental Research Institute, University of California, 10833 Le Conte Avenue, 73-024 CHS, Los Angeles, CA, 90095, USA

    Lei Zhang, Hua Xiao, Hui Zhou, Jieping Yang, Ole Brinkmann, Xinmin Yan, David Akin, No-Hee Park & David T. W. Wong

  2. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, 90095, USA

    David Chia

  3. Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, 90095, USA

    Jay M. Lee, David Chia, No-Hee Park & David T. W. Wong

  4. Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, 90095, USA

    David Elashoff

  5. Division of Head and Neck Surgery/Otolaryngology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, 90095, USA

    David T. W. Wong

  6. Henry Samueli School of Engineering and Applied Science, University of California-Los Angeles, Los Angeles, CA, 90095, USA

    David T. W. Wong

  7. Dental Research Institute, School of Dentistry, University of California-Los Angeles, 10833 Le Conte Avenue, 73-017 CHS, Los Angeles, CA, 90095, USA

    David T. W. Wong

  8. David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, 90095, USA

    Silverio Santiago & No-Hee Park

  9. Department of Surgery, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, 90095, USA

    Jay M. Lee

  10. Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, 90095, USA

    Edward B. Garon

Authors
  1. Lei Zhang
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Hua Xiao
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Hui Zhou
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Silverio Santiago
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Jay M. Lee
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Edward B. Garon
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Jieping Yang
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Ole Brinkmann
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Xinmin Yan
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. David Akin
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. David Chia
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. David Elashoff
    View author publications

    You can also search for this author inPubMed Google Scholar

  13. No-Hee Park
    View author publications

    You can also search for this author inPubMed Google Scholar

  14. David T. W. Wong
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Hua Xiao.

Additional information

L. Zhang and H. Xiao contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 86 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, L., Xiao, H., Zhou, H. et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell. Mol. Life Sci. 69, 3341–3350 (2012). https://doi.org/10.1007/s00018-012-1027-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-012-1027-0

Keywords